Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...
The overhaul of US science kicked off within hours of Trump’s inauguration on 20 January, when he signed dozens of executive ...
How much has been cut or halted remains unclear; the Trump administration has not released a comprehensive, reliable accounting.
Incyte and Genesis Therapeutics have agreed to discover and optimize at least two initial small molecule compounds through Genesis’s AI platform, Genesis Exploration of Molecular Space (GEMS).
YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic ...
Northwestern University researchers have identified structural features in engineered cell receptors that correlate with ...
Experts noted that rapid and extreme weight loss can introduce unique risks, such as a weakened immune system and malnourishment, as well as potentially too much muscle loss. They’re also concerned ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
Scientific studies on neurodegenerative diseases, sleep, and consumer products aim to set new standards for safety, accuracy, ...
New board reflects company's added focus on oncology & autoimmune diseases; SARASOTA, Fla. and MIAMI, Feb. 19, 2025 (GLOBE ...
Dr. Terence Kelly named interim CEO and Prof. Damian O'Connell named Chair of the Scientific Advisory Board, joins Board of Directors- Appointment of US-based CEO completes the ...
Dr. Aleix Prat, an internationally recognized leader in drug and biomarker development appointed Chair of the Advisory BoardDr. Jutta Amersdorffer appointed as Chief Medical Officer and Stéphane ...